IL117110A - Purification of vitamin k dependent coagulation factors by chromatography - Google Patents
Purification of vitamin k dependent coagulation factors by chromatographyInfo
- Publication number
- IL117110A IL117110A IL11711096A IL11711096A IL117110A IL 117110 A IL117110 A IL 117110A IL 11711096 A IL11711096 A IL 11711096A IL 11711096 A IL11711096 A IL 11711096A IL 117110 A IL117110 A IL 117110A
- Authority
- IL
- Israel
- Prior art keywords
- vitamin
- chromatography
- factors
- dependent
- chromatographic
- Prior art date
Links
- 230000001419 dependent effect Effects 0.000 title claims abstract description 35
- 229940046010 vitamin k Drugs 0.000 title claims abstract description 34
- 108010039209 Blood Coagulation Factors Proteins 0.000 title claims abstract description 28
- 102000015081 Blood Coagulation Factors Human genes 0.000 title claims abstract description 28
- 239000003114 blood coagulation factor Substances 0.000 title claims abstract description 28
- 238000004587 chromatography analysis Methods 0.000 title claims abstract description 18
- 238000000746 purification Methods 0.000 title claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 50
- 229930003448 Vitamin K Natural products 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 33
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims abstract description 33
- 235000019168 vitamin K Nutrition 0.000 claims abstract description 33
- 239000011712 vitamin K Substances 0.000 claims abstract description 33
- 150000003721 vitamin K derivatives Chemical class 0.000 claims abstract description 33
- 108010012557 prothrombin complex concentrates Proteins 0.000 claims abstract description 17
- 239000000243 solution Substances 0.000 claims abstract description 17
- -1 2-hydroxyaminopropyl groups Chemical group 0.000 claims abstract description 15
- 238000001042 affinity chromatography Methods 0.000 claims abstract description 11
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical class OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960002897 heparin Drugs 0.000 claims abstract description 9
- 229920000669 heparin Polymers 0.000 claims abstract description 9
- 238000005406 washing Methods 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 125000006850 spacer group Chemical group 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 3
- 238000011210 chromatographic step Methods 0.000 claims abstract description 3
- 238000000926 separation method Methods 0.000 claims abstract description 3
- 239000007853 buffer solution Substances 0.000 claims abstract 4
- 108010076282 Factor IX Proteins 0.000 claims description 31
- 102100022641 Coagulation factor IX Human genes 0.000 claims description 30
- 229960004222 factor ix Drugs 0.000 claims description 30
- 210000002381 plasma Anatomy 0.000 claims description 21
- 241000700605 Viruses Species 0.000 claims description 15
- 230000002779 inactivation Effects 0.000 claims description 15
- 239000011159 matrix material Substances 0.000 claims description 11
- 101800004937 Protein C Proteins 0.000 claims description 7
- 102000017975 Protein C Human genes 0.000 claims description 7
- 229940096437 Protein S Drugs 0.000 claims description 7
- 102000029301 Protein S Human genes 0.000 claims description 7
- 108010066124 Protein S Proteins 0.000 claims description 7
- 101800001700 Saposin-D Proteins 0.000 claims description 7
- 229960000856 protein c Drugs 0.000 claims description 7
- 238000005571 anion exchange chromatography Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 5
- 238000011097 chromatography purification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims 1
- 238000005349 anion exchange Methods 0.000 abstract description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 54
- 239000000872 buffer Substances 0.000 description 31
- 239000011780 sodium chloride Substances 0.000 description 27
- 239000003446 ligand Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 229910052799 carbon Inorganic materials 0.000 description 9
- 239000012141 concentrate Substances 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 8
- 238000011084 recovery Methods 0.000 description 6
- 239000012876 carrier material Substances 0.000 description 5
- 239000003599 detergent Substances 0.000 description 5
- 238000010828 elution Methods 0.000 description 4
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 4
- GQPVFBDWIUVLHG-UHFFFAOYSA-N [2,2-bis(hydroxymethyl)-3-(2-methylprop-2-enoyloxy)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(CO)(CO)COC(=O)C(C)=C GQPVFBDWIUVLHG-UHFFFAOYSA-N 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000012564 Q sepharose fast flow resin Substances 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000014599 transmission of virus Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19504852A DE19504852C2 (de) | 1995-02-15 | 1995-02-15 | Verfahren zur Reinigung Vitamin K-abhängiger Gerinnungsfaktoren durch Affinitäts-Chromatographie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL117110A0 IL117110A0 (en) | 1996-06-18 |
| IL117110A true IL117110A (en) | 2002-05-23 |
Family
ID=7753901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11711096A IL117110A (en) | 1995-02-15 | 1996-02-12 | Purification of vitamin k dependent coagulation factors by chromatography |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0813597B1 (de) |
| AT (1) | ATE341617T1 (de) |
| AU (1) | AU4830596A (de) |
| DE (2) | DE19504852C2 (de) |
| DK (1) | DK0813597T3 (de) |
| ES (1) | ES2274524T3 (de) |
| IL (1) | IL117110A (de) |
| PT (1) | PT813597E (de) |
| WO (1) | WO1996025490A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6387633B1 (en) * | 2001-05-11 | 2002-05-14 | Supratek Pharma, Inc. | Method for identifying unstable genes |
| KR100667860B1 (ko) | 2005-10-18 | 2007-01-11 | 주식회사 녹십자 | 고순도 사람 혈액응고 제9인자의 정제 방법 |
| WO2009141384A2 (en) * | 2008-05-21 | 2009-11-26 | Novo Nordisk A/S | Process for the purification of factor vii polypeptides using affinity resins comprising specific ligands |
| EP2652491B1 (de) | 2010-12-15 | 2017-11-29 | Baxalta GmbH | Eluatsammlung mit leitfähigkeitsgradient |
| BRPI1105317A2 (pt) | 2011-01-24 | 2013-04-30 | Fundacco Hemoct De Ribeirco Preto | produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2045167T5 (es) * | 1987-10-23 | 1996-07-01 | Centre Regional De Transfusion | Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas. |
| DE3826792C1 (de) * | 1988-08-06 | 1989-07-06 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
| DE3914869C1 (de) * | 1989-05-05 | 1990-08-09 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
| IT1262899B (it) * | 1992-03-27 | 1996-07-22 | Sclavo Spa | Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano |
-
1995
- 1995-02-15 DE DE19504852A patent/DE19504852C2/de not_active Expired - Fee Related
-
1996
- 1996-02-10 DK DK96904055T patent/DK0813597T3/da active
- 1996-02-10 AT AT96904055T patent/ATE341617T1/de active
- 1996-02-10 AU AU48305/96A patent/AU4830596A/en not_active Abandoned
- 1996-02-10 EP EP96904055A patent/EP0813597B1/de not_active Expired - Lifetime
- 1996-02-10 PT PT96904055T patent/PT813597E/pt unknown
- 1996-02-10 WO PCT/EP1996/000569 patent/WO1996025490A1/en not_active Ceased
- 1996-02-10 ES ES96904055T patent/ES2274524T3/es not_active Expired - Lifetime
- 1996-02-10 DE DE69636594T patent/DE69636594T2/de not_active Expired - Lifetime
- 1996-02-12 IL IL11711096A patent/IL117110A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0813597B1 (de) | 2006-10-04 |
| DE19504852A1 (de) | 1996-08-22 |
| DE69636594T2 (de) | 2007-05-16 |
| DE19504852C2 (de) | 2003-01-23 |
| ES2274524T3 (es) | 2007-05-16 |
| DK0813597T3 (da) | 2007-02-05 |
| PT813597E (pt) | 2006-12-29 |
| IL117110A0 (en) | 1996-06-18 |
| EP0813597A1 (de) | 1997-12-29 |
| DE69636594D1 (de) | 2006-11-16 |
| ATE341617T1 (de) | 2006-10-15 |
| WO1996025490A1 (en) | 1996-08-22 |
| AU4830596A (en) | 1996-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR970010923B1 (ko) | 혈장단백질의 크로마토그래피 분리법 | |
| JP4445202B2 (ja) | 治療的使用のためのヒト免疫グロブリン濃縮物の調製方法 | |
| US5679776A (en) | Process for preparing a concentrate of blood coagulation factor VIII-von willebrand factor complex from total plasma | |
| JPH0764750B2 (ja) | アルフア−１−プロテイナ−ゼ阻害剤の製造方法 | |
| JPS61275210A (ja) | ウイルス及び発熱原不活性化剤を用いる固相に吸着させた生物医学的生成物及び製薬生成物の処理法 | |
| JP4250771B2 (ja) | カチオン交換クロマトグラフィーによる因子ＶＩＩＩ／ｖＷＦ複合体の精製方法 | |
| EP0617049B1 (de) | Verfahren zur Isolation von hoch angereicherten Faktoren IX, X und II vom Prothrombin komplex oder menschlichem Plasma | |
| CA2059979C (en) | Complex containing coagulation factor ix | |
| JP2579217B2 (ja) | 凝固因子▲ｉｉ▼、▲ｖｉｉ▼、▲ｉｘ▼およびｘの１または２以上を濃縮する方法 | |
| EP0391974B1 (de) | Verfahren zur Reinigung von Vitamin-K-abhängigen Blutgerinnungsfaktoren | |
| HU219828B (hu) | Eljárás K-vitamin-függő proteinek izolálására és tisztítására | |
| EP0813597B1 (de) | Prozess zur reinigung von vitamin k abhängigen koagulationsfaktoren durch chromatographie | |
| US5445958A (en) | Process for purifying blood clotting factors | |
| CA2258740C (en) | Manufacturing process for the production of purified transferrin | |
| EP0650364B1 (de) | Reinigung von faktor ix | |
| JPH08116985A (ja) | 遺伝子操作に由来するヒト血清アルブミンの精製方法 | |
| CA1256042A (en) | Process for the purification of hbsag | |
| Taniguchi et al. | Purification of staphylococcal Protein A by affinity precipitation: dissociation of Protein A from the adsorbent with chemical reagents | |
| AU627446C (en) | Chemical process | |
| AU665452C (en) | Purification of factor IX |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HE | Change of address of proprietor(s) | ||
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |